scorecardresearch
Sunday, July 20, 2025
TopicSinovac

Topic: Sinovac

China’s Sinovac Covid vaccine’s efficacy uncertain despite Brazil, Turkey results

Turkey said a trial of Sinovac’s vaccine showed an estimated efficacy rate of 91.25%. However, Sao Paulo Health Secretary said the vaccine 'didn’t reach 90%' efficacy.

Brazil trial shows Sinovac vaccine above 50% effective, but researchers delay full results

Sinovac is betting on a successful vaccine to inoculate more people around the world, especially in developing countries that will have limited access to the Pfizer and Moderna shots.

China claims one million Covid vaccines already given, planning further shots

Vaccines developed by Sinovac Biotech Ltd. & China National Biotec Group Co. have been dispensed in the country since they were granted emergency-use authorization in July.

China’s Sinovac Biotech says Covid vaccine creates antibodies, efficacy yet to be determined

The clarification came after Sinovac’s Indonesian partner, PT Bio Farma, said the vaccine had proven 97% effective in early clinical trials.

Final stage of China’s Sinovac vaccine trial halted in Brazil after serious adverse event

Halt comes after Sinovac became the focus of an escalating feud in Brazil, when President Bolsonaro last month stepped up criticism saying China lacked credibility.

On Camera

Fauja Singh’s death shows Indian roads remain a national emergency—474 lives lost every day

Fauja Singh, 114, died after being hit by a speeding car. His death renews questions about India’s deadly roads, rising accidents, and poor traffic discipline.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.